These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 24675890)

  • 1. Doxorubicin enhances Snail/LSD1-mediated PTEN suppression in a PARP1-dependent manner.
    Lin Y; Kang T; Zhou BP
    Cell Cycle; 2014; 13(11):1708-16. PubMed ID: 24675890
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PARP inhibitor ABT-888 affects response of MDA-MB-231 cells to doxorubicin treatment, targeting Snail expression.
    Mariano G; Ricciardi MR; Trisciuoglio D; Zampieri M; Ciccarone F; Guastafierro T; Calabrese R; Valentini E; Tafuri A; Del Bufalo D; Caiafa P; Reale A
    Oncotarget; 2015 Jun; 6(17):15008-21. PubMed ID: 25938539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nuclear PTEN interferes with binding of Ku70 at double-strand breaks through post-translational poly(ADP-ribosyl)ation.
    Guan J; Zhao Q; Mao W
    Biochim Biophys Acta; 2016 Dec; 1863(12):3106-3115. PubMed ID: 27741411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Requirement of the histone demethylase LSD1 in Snai1-mediated transcriptional repression during epithelial-mesenchymal transition.
    Lin T; Ponn A; Hu X; Law BK; Lu J
    Oncogene; 2010 Sep; 29(35):4896-904. PubMed ID: 20562920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PARP1-LSD1 functional interplay controls transcription of SOD2 that protects human pro-inflammatory macrophages from death under an oxidative condition.
    Tokarz P; Płoszaj T; Regdon Z; Virág L; Robaszkiewicz A
    Free Radic Biol Med; 2019 Feb; 131():218-224. PubMed ID: 30529301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibiting interactions of lysine demethylase LSD1 with snail/slug blocks cancer cell invasion.
    Ferrari-Amorotti G; Fragliasso V; Esteki R; Prudente Z; Soliera AR; Cattelani S; Manzotti G; Grisendi G; Dominici M; Pieraccioli M; Raschellà G; Chiodoni C; Colombo MP; Calabretta B
    Cancer Res; 2013 Jan; 73(1):235-45. PubMed ID: 23054398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The malignant brain tumor (MBT) domain protein SFMBT1 is an integral histone reader subunit of the LSD1 demethylase complex for chromatin association and epithelial-to-mesenchymal transition.
    Tang M; Shen H; Jin Y; Lin T; Cai Q; Pinard MA; Biswas S; Tran Q; Li G; Shenoy AK; Tongdee E; Lin S; Gu Y; Law BK; Zhou L; Mckenna R; Wu L; Lu J
    J Biol Chem; 2013 Sep; 288(38):27680-27691. PubMed ID: 23928305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GATA3 cooperates with PARP1 to regulate CCND1 transcription through modulating histone H1 incorporation.
    Shan L; Li X; Liu L; Ding X; Wang Q; Zheng Y; Duan Y; Xuan C; Wang Y; Yang F; Shang Y; Shi L
    Oncogene; 2014 Jun; 33(24):3205-16. PubMed ID: 23851505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Poly(ADP-ribose)-dependent regulation of Snail1 protein stability.
    Rodríguez MI; González-Flores A; Dantzer F; Collard J; de Herreros AG; Oliver FJ
    Oncogene; 2011 Oct; 30(42):4365-72. PubMed ID: 21577210
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Poly(ADP-ribosyl)ation of BRD7 by PARP1 confers resistance to DNA-damaging chemotherapeutic agents.
    Hu K; Wu W; Li Y; Lin L; Chen D; Yan H; Xiao X; Chen H; Chen Z; Zhang Y; Xu S; Guo Y; Koeffler HP; Song E; Yin D
    EMBO Rep; 2019 May; 20(5):. PubMed ID: 30940648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The histone methyltransferase SMYD2 methylates PARP1 and promotes poly(ADP-ribosyl)ation activity in cancer cells.
    Piao L; Kang D; Suzuki T; Masuda A; Dohmae N; Nakamura Y; Hamamoto R
    Neoplasia; 2014 Mar; 16(3):257-64, 264.e2. PubMed ID: 24726141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PARP1-SNAI2 transcription axis drives resistance to PARP inhibitor, Talazoparib.
    Ding X; Zhu Z; Lapek J; McMillan EA; Zhang A; Chung CY; Dubbury S; Lapira J; Firdaus S; Kang X; Gao J; Oyer J; Chionis J; Rollins RA; Li L; Niessen S; Bagrodia S; Zhang L; VanArsdale T
    Sci Rep; 2022 Jul; 12(1):12501. PubMed ID: 35864202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of p38 signaling and poly(ADP-ribosyl)ation-induced metabolic collapse in the osteogenic differentiation-coupled cell death pathway.
    Robaszkiewicz A; Valkó Z; Kovács K; Hegedűs C; Bakondi E; Bai P; Virág L
    Free Radic Biol Med; 2014 Nov; 76():69-79. PubMed ID: 25078118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MORC2 regulates DNA damage response through a PARP1-dependent pathway.
    Zhang L; Li DQ
    Nucleic Acids Res; 2019 Sep; 47(16):8502-8520. PubMed ID: 31616951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PARP targeting counteracts gliomagenesis through induction of mitotic catastrophe and aggravation of deficiency in homologous recombination in PTEN-mutant glioma.
    Majuelos-Melguizo J; Rodríguez MI; López-Jiménez L; Rodríguez-Vargas JM; Martí Martín-Consuegra JM; Serrano-Sáenz S; Gavard J; de Almodóvar JM; Oliver FJ
    Oncotarget; 2015 Mar; 6(7):4790-803. PubMed ID: 25576921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Poly(ADP-ribosyl)ation of histone H1 correlates with internucleosomal DNA fragmentation during apoptosis.
    Yoon YS; Kim JW; Kang KW; Kim YS; Choi KH; Joe CO
    J Biol Chem; 1996 Apr; 271(15):9129-34. PubMed ID: 8621564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular mechanism of poly(ADP-ribosyl)ation by PARP1 and identification of lysine residues as ADP-ribose acceptor sites.
    Altmeyer M; Messner S; Hassa PO; Fey M; Hottiger MO
    Nucleic Acids Res; 2009 Jun; 37(11):3723-38. PubMed ID: 19372272
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Poly(ADP-ribose) polymerase 1 is a key regulator of estrogen receptor α-dependent gene transcription.
    Zhang F; Wang Y; Wang L; Luo X; Huang K; Wang C; Du M; Liu F; Luo T; Huang D; Huang K
    J Biol Chem; 2013 Apr; 288(16):11348-57. PubMed ID: 23493398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HMG20A is required for SNAI1-mediated epithelial to mesenchymal transition.
    Rivero S; Ceballos-Chávez M; Bhattacharya SS; Reyes JC
    Oncogene; 2015 Oct; 34(41):5264-76. PubMed ID: 25639869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LSD1 Inhibition Promotes Epithelial Differentiation through Derepression of Fate-Determining Transcription Factors.
    Egolf S; Aubert Y; Doepner M; Anderson A; Maldonado-Lopez A; Pacella G; Lee J; Ko EK; Zou J; Lan Y; Simpson CL; Ridky T; Capell BC
    Cell Rep; 2019 Aug; 28(8):1981-1992.e7. PubMed ID: 31433976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.